Ovation Science Seeks Greater US Distribution as the Cannabis Market Continues to Grow PolyPid Granted Breakthrough Therapy Designation from FDA for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Colorectal Surgery
PETAH TIKVA, Israel, Nov. 24, 2020 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), a Phase…
Kiniksa Pharmaceuticals to Present at the Evercore ISI 3rd Annual HealthCONx Conference
HAMILTON, Bermuda, Nov. 24, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today…
Spectral Medical Announces that its wholly owned subsidiary Dialco Medical has received MDSAP certification
MDSAP is the highest quality and regulatory standard in the medical device industry TORONTO, Nov….
Oncorus to Participate in Fireside Chats at Upcoming Piper Sandler Annual Healthcare Conference and Evercore ISI HealthCONx Conference
CAMBRIDGE, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) — Oncorus, Inc. (Nasdaq:ONCR), a viral immunotherapies company…
Allena Pharmaceuticals to Present Virtually at Evercore ISI 3rd Annual HealthCONx Conference
NEWTON, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
SEngine Precision Medicine to Present Data from Predictive Value of PARIS® Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium
SEATTLE, Nov. 24, 2020 (GLOBE NEWSWIRE) — SEngine Precision Medicine, a precision oncology company revolutionizing…
OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
GAITHERSBURG, Md., Nov. 24, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision…
Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib
Trial enrolled patients ahead of originally anticipated timeline despite COVID-19 pandemic SOUTH SAN FRANCISCO, Calif.,…
Mustang Bio Announces Positive Opinion from the European Medicines Agency on Orphan Drug Designation for Its Lentiviral Gene Therapy for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)
WORCESTER, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) — via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP),…